Hos patienter med psoriasis artrit blev der påvist adalimumab antistoffer hos 38/ 376 patienter (10%) behandlet med adalimumab.
In patients with psoriatic arthritis, adalimumab antibodies were identified in 38/ 376 subjects (10%)